Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer. Traphagen NA, Schwartz GN, Tau S, Roberts AM, et al. Clin Cancer Res 2023 Jul 13:CCR-23-0488. doi: 10.1158/1078-0432.CCR-23-0488.

Read + Share

Amedeo Smart

Independent Medical Education

Traphagen NA, Schwartz GN, Tau S, Roberts AM, et al. Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer. Clin Cancer Res 2023 Jul 13:CCR-23-0488. doi: 10.1158/1078-0432.CCR-23-0488.
PMID: 37439680